Literature DB >> 14767033

Factor H deficiency and fibrillary glomerulopathy.

Zelal Bircan1, Demet Toprak, Isin Kilicaslan, Seyhun Solakoglu, Veli Uysal, Denis Ponard, Gulcan Turker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14767033     DOI: 10.1093/ndt/gfg605

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

Review 1.  Dense deposit disease.

Authors:  Richard J H Smith; Claire L Harris; Matthew C Pickering
Journal:  Mol Immunol       Date:  2011-05-24       Impact factor: 4.407

2.  Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate.

Authors:  Hee Yeon Cho; Byong Sop Lee; Kyung Chul Moon; Il Soo Ha; Hae Il Cheong; Yong Choi
Journal:  Pediatr Nephrol       Date:  2007-02-13       Impact factor: 3.714

Review 3.  aHUS caused by complement dysregulation: new therapies on the horizon.

Authors:  Aoife M Waters; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2010-06-18       Impact factor: 3.714

Review 4.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

5.  Fibrillary glomerulonephritis and renal failure in a child with systemic lupus erythematosus.

Authors:  Shina Menon; Xu Zeng; Rudolph Valentini
Journal:  Pediatr Nephrol       Date:  2009-03-24       Impact factor: 3.714

6.  A case of fibrillary glomerulonephritis associated with thrombotic microangiopathy and anti-glomerular basement membrane antibody.

Authors:  Akishi Momose; Taku Nakajima; Shigetoshi Chiba; Kenjirou Kumakawa; Yasuo Shiraiwa; Nobuhiro Sasaki; Kazuo Watanabe; Etsuko Kitano; Mitiyo Hatanaka; Hajime Kitamura
Journal:  Nephron Extra       Date:  2015-02-27

7.  Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy.

Authors:  Muhammad M Javaid; Helen Denley; Senyo Tagboto
Journal:  BMC Nephrol       Date:  2007-05-09       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.